Sargent Investment Group LLC raised its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 14.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 371,049 shares of the construction company's stock after purchasing an additional 47,680 shares during the quarter. Sargent Investment Group LLC owned 0.45% of Aspen Aerogels worth $4,723,000 as of its most recent filing with the Securities and Exchange Commission.
Other large investors also recently modified their holdings of the company. nVerses Capital LLC boosted its position in Aspen Aerogels by 45.0% in the third quarter. nVerses Capital LLC now owns 5,800 shares of the construction company's stock valued at $161,000 after buying an additional 1,800 shares in the last quarter. Journey Strategic Wealth LLC acquired a new position in shares of Aspen Aerogels in the 4th quarter worth approximately $178,000. Ballentine Partners LLC grew its position in Aspen Aerogels by 19.2% during the 4th quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company's stock worth $189,000 after acquiring an additional 2,565 shares during the last quarter. Quest Partners LLC raised its position in Aspen Aerogels by 263.3% in the 3rd quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock valued at $205,000 after purchasing an additional 5,361 shares during the last quarter. Finally, Pursue Wealth Partners LLC acquired a new position in Aspen Aerogels in the third quarter worth $222,000. 97.64% of the stock is currently owned by institutional investors.
Aspen Aerogels Stock Down 1.2 %
Shares of NYSE:ASPN traded down $0.15 during midday trading on Friday, reaching $11.49. The company had a trading volume of 1,068,583 shares, compared to its average volume of 1,390,847. Aspen Aerogels, Inc. has a 1-year low of $10.67 and a 1-year high of $33.15. The stock has a market cap of $942.34 million, a PE ratio of 1,149.65 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The business's 50 day moving average price is $12.50 and its 200 day moving average price is $18.87.
Analysts Set New Price Targets
A number of analysts recently commented on ASPN shares. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an "overweight" rating for the company in a research report on Tuesday, October 22nd. Barclays lowered their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a research report on Tuesday, November 12th. Canaccord Genuity Group cut their price objective on shares of Aspen Aerogels from $28.00 to $20.00 and set a "buy" rating on the stock in a report on Thursday, January 16th. Roth Mkm reduced their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a research note on Friday, November 8th. Finally, HC Wainwright reiterated a "buy" rating and set a $30.00 target price on shares of Aspen Aerogels in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $29.11.
Read Our Latest Research Report on ASPN
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Stories

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.